Business
With a reputation as the ‘pharmacy of the world,’ India is geared to mass-produce COVID-19 vaccines – ABC News
India has become a global powerhouse for generic pharmaceutical drugs and the hope is that this could make Indian companies like the Serum Institute, which is the…
While the Pfizer COVID-19 vaccine rollout in the United Kingdom and the United States has been widely heralded as the beginning of the end of the pandemic, much of the developing world has its hopes set elsewhere.
India has become a global powerhouse for generic pharmaceutical drugs and accounts for about 60 per cent of the world’s vaccine supplies, earning a reputation as the “pharmacy of the world”.
And unlike the Pfizer vaccine which is safe and effective but relatively expensive and unstable…
-
Noosa News12 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
General20 hours agoWotjobaluk Nations Festival marks landmark native title recognition
-
General14 hours agoAustralian luger Alex Ferlazzo makes stunning recovery during run after falling off his sled
-
Business24 hours agoWhat Warren Buffett’s latest portfolio moves say about the market